Microencapsulation with alginate/CaCO 3: A strategy for improved phage therapy

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Colom, Joan ^a   Cano Sarabia, Mary ^b   Otero, Jennifer ^a   Aríñez Soriano, Javier ^b   Cortés, Pilar ^a   Maspoch, Daniel ^b,c   Llagostera, Montserrat ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CALCIUM CARBONATE; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL; ANIMAL SALMONELLOSIS; BODY FLUID; CECUM; CHEMISTRY; CHICKEN; DRUG FORMULATION; PHAGE THERAPY; PHYSIOLOGY; PROCEDURES; SALMONELLA; THREE DIMENSIONAL IMAGING; VIROLOGY;

ALGINATES; ANIMALS; BODY FLUIDS; CALCIUM CARBONATE; CECUM; CHICKENS; DRUG COMPOUNDING; GLUCURONIC ACID; HEXURONIC ACIDS; IMAGING, THREE-DIMENSIONAL; PHAGE THERAPY; SALMONELLA; SALMONELLA INFECTIONS, ANIMAL;

EID: 85010799988     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41441     Document Type: Article

References (41)

1. Liebana, E., et al. Public health risks of enterobacterial isolates producing extended-spectrum beta-lactamases or AmpC betalactamases in food, food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, , control options. Clin. Infect. Dis. 56, 1030-1037, doi: 10.1093/cid/cis1043 (2013).
2. European Centre for Disease Prevention, Control (ECDC), European Food Safety Authority (EFSA), European Medicines Agency (EMEA). Joint opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA Journal 7(11), 1372, doi: 10.2903/j.efsa.2009.1372 (2009).
3. Sillankorva, S. M., Oliveira, H., Azeredo, J. Bacteriophages, their role in food safety. Int. J. Microbiol. 2012, 863945, doi: 10.1155/2012/863945 (2012).
4. Endersen, L., et al. Phage therapy in the food industry. Annu. Rev. Food Sci. Technol. 5, 327-349, doi: 10.1146/annurevfood-030713-092415 (2014).
5. Abedon, S. T., Kuhl, S. J., Blasdel, B. G., Kutter, E. M. Phage treatment of human infections. Bacteriophage 1, 2, 66-85, doi: 10.4161/bact.1.2.15845 (2011).
6. Vandenheuvel, D., Lavigne, R., Brüssow, H. Bacteriophage Therapy: advances in formulation strategies, human clinical trials. Annu. Rev. Virol. 2, 599-618, doi: 10.1146/annurev-virology-100114-054915 (2015).
7. Ryan, E. M., Gorman, S. P., Donnelly, R. F., Gilmore, B. F. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration, timing influence the success of phage therapy. J. Pharm. Pharmacol. 63, 1253-1264, doi: 10.1111/j.2042-7158.2011.01324.x (2011).
8. Ma, Y., et al. Microencapsulation of bacteriophage Felix O1 into chitosan-alginate microspheres for oral delivery. Appl. Environ. Microbiol. 74, 4799-4805, doi: 10.1128/AEM.00246-08 (2008).
9. Wang, Q., Sabour, P. M. Encapsulation, controlled release of bacteriophages for food animal production. In Bacteriophages In The Control Of Food-And Waterbone Pathogens. (eds Parviz, M., Sabour, P. M., Mansel, W., Griffiths, M. W.) (ASM Press, Washington, DC, 2010).
10. Ma, Y., et al. Enhanced alginate microspheres as means of oral delivery of bacteriophage for reducing Staphylococcus aureus intestinal carriage. Food Hydrocoll. 26, 434-440, doi: 10.1016/j.foodhyd.2010.11.017 (2012).
11. Bardina, C., Spricigo, D. A., Cortés, P., Llagostera, M. Significance of the bacteriophage treatment schedule in reducing Salmonella colonization of poultry. Appl. Environ. Microbiol. 78, 6600-6607, doi: 10.1128/AEM.01257-12 (2012).
12. Choinska-Pulit, A., Mitua, P., Sliwka, P., aba, W., Skaradzinska, A. Bacteriophage encapsulation: trends, potential applications. Trends Food Sci. Tech. 45, 212e221, doi: 10.1016/j.tifs.2015.07.001 (2015).
13. Hussain, M. A., et al. Use of encapsulated bacteriophages to enhance farm to fork food safety. Crit. Rev. Food Sci. Nutr. 11, 0, doi: 10.1080/10408398.2015.1069729 (2015).
14. Kailasapathy, K. Microencapsulation of probiotc bacteria: technology, potenctial applications. Curr. Issues Intest. Microbiol. 3, 39-48 (2002).
15. D'Orazio, G., et al. Microencapsulation of new probiotic formulations for gastrointestinal delivery: in vitro study of assess viability, biological properties. Appl. Microbiol. Biotechnol. 99, 9779-9789, doi: 10.1007/s00253-015-6853-1 (2015).
16. Tang, Z., et al. Whey protein improves survival, release characteristics of bacteriophage FelixO1 encapsulated in alginate microspheres. Food Res. Int. 52, 460-466, doi: 10.1016/j.foodres.2012.12.037 (2013).
17. Tang, Z., Huang, X., Sabour, P. M., Chambers, J. R., Wang, Q. Preparation, characterization of dry powder bacteriophage K for intestinal delivery through oral administration. LWT-Food Sci. Technol. 60, 263-270, doi: 10.1016/j.lwt.2014.08.012 (2015).
18. Samtlebe, M., et al. Carrier systems for bacteriophages to supplement food systems: Encapsulation, controlled release to modulate the human gut microbiota. LWT-Food Sci. Technol. 68, 334-340, doi: 10.1016/j.lwt.2015.12.039 (2016).
19. Lee K. Y., Mooney D. J. Alginate: properties, biomedical applications. Prog. Polym. Sci. 37(1), 106-126, doi: 10.1016/j. progpolymsci.2011.06.003 (2012).
20. Sosnik, A. Alginate particles as platform for drug delivery by the oral route: state-of-the-art. ISRN Pharm. 2014, 926157, doi: 10.1155/2014/926157 (2014).
21. Wall, S. K., Zhang, J., Rostagno, M. H., Ebner, P. D. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl. Environ. Microbiol. 76, 48-53, doi: 10.1128/AEM.00785-09 (2010).
22. Saez, A. C., Zhang, J., Rostagno, M. H., Ebner, P. D. Direct feeding of microencapsulated bacteriophages to reduce Salmonella colonization in pigs. Foodborne Pathog. Dis. 8, 1269-1274, doi: 10.1089/fpd.2011.0905 (2011).
23. Spricigo, D. A., Bardina, C., Cortés, P., Llagostera, M. Use of a bacteriophage cocktail to control Salmonella in food, the food industry. Int. J. Food Microbiol. 165, 169-174, doi: 10.1016/j.ijfoodmicro.2013.05.009 (2013).
24. Colom, J., et al. L Liposome-encapsulated bacteriophages for enhanced oral phage therapy against Salmonella spp. Appl. Environ. Microbiol. 81, 4841-4849, doi: 10.1128/AEM.00812-15 (2015).
25. Dini, C., Islan, G. A., de Urraza, P. J., Castro, G. R. Novel biopolymer matrices for microencapsulation of phages: enhanced protection against acidity, protease activity. Macromol Biosci 12, 1200-1208, doi: 10.1002/mabi.201200109 (2012).
26. Dini, C., Islan, G. A., Castro, G. R. Characterization, stability analysis of biopolymeric matrices designed for phage-controlled release. Appl. Biochem. Biotechnol. 174, 2031-2047, doi: 10.1007/s12010-014-1152-3 (2014).
27. Stanford, K., et al. Oral delivery systems for encapsulated bacteriophages targeted at Escherichia coli O157:H7 in feedlot cattle. J. Food Prot. 7, 1304-1312 (2010).
28. Jiménez-Moreno, E., González-Alvarado, J. M., Gónzalez-Sánchez, D., Lázaro, R., Mateos, G. G. Effects of type, particle size of dietary fiber on growth performance, digestive traits of broilers from 1 to 21 days of age. Poult. Sci. 89, 2197-2212, doi: 10.3382/ps.2010-00771 (2010).
29. Sacranie, A., et al. The effect of insoluble fiber, intermittent feeding on gizzard development, gut motility, performance of broiler chickens. Poult. Sci. 91, 693-700, doi: 10.3382/ps.2011-01790 (2012).
30. Barr, J. J., et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl. Acad. Sci. USA 110, 10771-1776, doi: 10.1073/pnas.1305923110 (2013).
31. Atterbury, R. J., et al. Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl. Environ. Microbiol. 73, 4543-4549, doi: 10.1128/AEM.00049-07 (2007).
32. George, M., Abraham, T. E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate, chitosan-a review. J. Control Release 114, 1-14, doi: 10.1016/j.jconrel.2006.04.017 (2006).
33. Payne, R. J., Jansen, V. A. Understanding bacteriophage therapy as a density-dependent kinetic process. J. Theor. Biol. 208, 37-48, doi: 10.1006/jtbi.2000.2198 (2001).
34. Payne, R. J., Jansen, V. A. Pharmacokinetic principles of bacteriophage therapy. Clin. Pharmacokinet. 42, 315-325, doi: 10.2165/00003088-200342040-00002 (2003).
35. Bull, J. J., Gill, J. J. The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages. Front. Microbiol. 5, 618, doi: 10.3389/fmicb.2014.00618 (2014).
36. Hurley, A., Maurer, J. J., Lee M. D. Using bacteriophages to modulate Salmonella colonization of the chicken's gastrointestinal tract: Lessons learned from in silico, in vivo modelling. Avian Dis. 52, 599-607, doi: 10.1637/8288-031808-reg.1 (2008).
37. Bardina, C., et al. Genetics, genomics of three new bacteriophages useful in the biocontrol of Salmonella. Front. Microbiol. 7, 545, doi: 10.3389/fmicb.2016.00545 (2016).
38. Green, M. R., Sambrook, J. In Molecular Cloning: A Laboratory Manual 4rd ed. (Cold Spring Harbor Laboratory Press, 2012).
39. International Organization for Standardization. Particle size analysis-Laser diffraction methods. ISO 13320:2009 http://www.iso. org/iso/catalogue-detail.htmcsnumber= 44929 (2009).
40. Hadjialirezaei, S. Coating Of Alginate Capsules. PhD Thesis. Norwegian University of Science, Technology (2013).
41. Musikasang, H., Tani, A., H-Kittikun, A., Maneerat, S. Probiotic potential of lactic acid bacteria isolated from chicken gastrointestinal digestive tract. World J. Microbiol. Biotechnol. 25, 1337-1345, doi: 10.1007/s11274-009-0020-8 (2009).